NFCA

Menu

Skip to content
  • Home
  • What Is NF?
    • Facts & Statistics
    • NF1
    • NF2
    • Schwannomatosis
  • Living With NF
    • NF Stories
    • Support Groups
    • Research
    • Helpful Links
  • How We Help
    • About Us
    • Clinics
    • Scholarship Programs
    • Publications
    • Fundraising Events
  • How You Can Help
    • Donate
    • Individual Fundraising
    • Volunteer
    • Online Programs
  • Events
    • Walk in the Wild
    • Walk at the Isle
    • NFCA Golf Scramble
    • Pittsburgh Marathon
  • News
  • Contact Us

Clinical Trial of Selumetinib

Posted on: January 10, 2017 by: webmaster

logoA phase I clinical trial of Selumetinib has shown some early promising results in children diagnosed with NF1. read more at “New Drug Shrinks Pediatric Tumors“.

Donate Now

Your donation helps ensure that the most promising projects are thoroughly explored and funded. View our donation page for all options or donate now using the Donate link below. The NFCA is a nonprofit organization under IRS Code Section 501 (c)(3), Federal Tax ID 25-1763156. Donate SO THAT WE MAY PROPERLY CREDIT/RECORD YOUR DONATION, PLEASE SELECT AN OPTION UNDER "USE THIS DONATION FOR". ON THE FOLLOWING PAGE, UNDER "WRITE A NOTE", LET US KNOW THE INDIVIDUAL BEING HONORED/MEMORIALIZED, THE SPECIFIC EVENT INFORMATION, AND/OR GENERAL ACKNOWLEDGEMENT INFORMATION.

Recent Posts

  • Thanks to the Marathon Planning Committee & Runners
  • 2022 Walk At The Isle
  • 2022 NFCA Golf Scramble
  • Hoffman Family Featured on Wake Up Warriors
  • The 27th Annual Walk in the Wild

Categories

  • Events
  • News
  • Patient Stories
  • Research
  • Resources

Amazon Smile

AmazonSmile-Logo Amazon will donate a percentage of your eligible purchases to the NFCA. Click Amazon Smile to get started.

Send Us An Email

info@nfpittsburgh.org

Give Us A Call

(412) 795-3029

Connect With Us

PO Box 14185
Pittsburgh, PA 15239
Copyright © 2022 Neurofibromatosis Clinics Association. All rights reserved.